Remimazolam-Based Anesthetic Management in a Patient with Severe Aortic Stenosis and Myelodysplastic Syndrome-Related Thrombocytopenia: A Case Report. [PDF]
J Clin MedLee SH, Cho SB, Choo H, Park J, Byun SH.
europepmc +1 more source
Genetics by genetic algorithm: Defining an ideal platelet donor population to support patients with HLA-mediated alloimmune refractoriness. [PDF]
TransfusionBlake JT +4 more
europepmc +1 more source
Anti-HLA class I IgG subclasses skew platelet activation mechanisms in transfusion refractoriness. [PDF]
HaematologicaCouvidou A +10 more
europepmc +1 more source
Analysis of influencing factors and predictive model construction for platelet transfusion efficacy in hematological patients. [PDF]
Front Med (Lausanne)Zou Y +5 more
europepmc +1 more source
European Management of Glanzmann's Thrombasthenia: A Survey of Current Clinical Practice. [PDF]
HaemophiliaFiore M +6 more
europepmc +1 more source
The evolving landscape of platelet therapy: risks, innovations, and clinical judgment. [PDF]
Ann HematolMushtaq A +5 more
europepmc +1 more source
Outcomes of recombinant activated factor VIIa (NovoSeven) therapy in glanzmann thrombasthenia: two case reports. [PDF]
Blood Coagul FibrinolysisAlmatar E, Alsharidah S, Hashem OA.
europepmc +1 more source
Anti-HLA antibody formation increases the chances of platelet refractoriness in platelet-transfused patients: a systematic review with meta-analysis. [PDF]
Hematol Transfus Cell TherCabral LJB +5 more
europepmc +1 more source
Recombinant Factor VIIa Prophylaxis in 2 Brothers with Bernard-Soulier Syndrome. [PDF]
Am J Case RepAlmatar E, Alsharidah S, Hashem OA.
europepmc +1 more source